Financials

News Ideas Discussions Technicals Seasonals

AVE fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to AVECHO BIOTECHNOLOGY LIMITED operating, investing, and financing activities

AVE free cash flow for H2 24 is -3.34 M AUD. For 2024, AVE free cash flow was -3.97 M AUD and operating cash flow was -3.97 M AUD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: AUD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—